Product NDC: | 52125-070 |
Proprietary Name: | Diamox Sequels |
Non Proprietary Name: | Acetazolamide |
Active Ingredient(s): | 500 mg/1 & nbsp; Acetazolamide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-070 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012945 |
Marketing Category: | NDA |
Start Marketing Date: | 20130221 |
Package NDC: | 52125-070-02 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (52125-070-02) |
NDC Code | 52125-070-02 |
Proprietary Name | Diamox Sequels |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (52125-070-02) |
Product NDC | 52125-070 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetazolamide |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130221 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | ACETAZOLAMIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |